Consumption of a high-fat high-fructose diet (western diet, [WD]) promotes vascular stiffness, a 20 critical factor in the development of cardiovascular disease (CVD). Obese and diabetic women 21 exhibit greater arterial stiffness than men, which contributes to the increased incidence of CVD 22 in these women. Further, high-fructose diets result in elevated plasma concentrations of uric acid 23 via xanthine oxidase (XO) activation, and uric acid elevation is also associated with increased 24 vascular stiffness. However, the mechanisms by which increased xanthine oxidase activity and 25 uric acid contribute to vascular stiffness in obese females remain to be fully uncovered. 
Introduction 44
Widespread consumption of diets rich in saturated fat and fructose (western diet, [WD] ) 45 leads to insulin resistance and obesity, which are critical factors in the pathogenesis of type 2 46 diabetes mellitus (DM2) and cardiovascular disease (CVD) (31). In turn, CVD accounts for over 47 50% of deaths in subjects with DM2 (36, 52) . Women affected by obesity, insulin resistance and 48 DM2 are at an especially high risk of developing CVD, with a 50% increased risk of death from 49 coronary artery disease (36) and 27% increased relative risk of stroke compared to men (57) . 50
Therefore, uncovering the mechanisms that link diet induced obesity to vascular dysfunction is 51 of paramount importance. Notably, vascular stiffness is a parameter that can be used to evaluate 52 vascular dysfunction and can be measured clinically using noninvasive techniques (60) . 53
Although it is a physiological phenomenon associated with aging, vascular stiffness is also a 54 biomarker that correlates independently with increased risk of CVD-related morbidity and 55 mortality (4, 12, 14, 34) . Conditions such as obesity and DM2 are characterized by accelerated 56 and enhanced vascular stiffness (69, 75) . Furthermore, under these conditions augmented 57 vascular stiffness occurs to a greater extent in women compared to men (56). Therefore, the 58 increased incidence and greater severity of CVD in diabetic women can be partially related to 59 increased vascular stiffness (14, 64) . 60
Fructose in contemporary diet derives mostly from abundantly available sucrose in table  61 sugar and high-fructose corn syrup, and appears to be a critical contributor to obesity and 62 associated metabolic abnormalities arising from consumption of WD. Indeed, excess dietary 63 ingestion of fructose strongly correlates with weight gain and impaired glucose tolerance in 64 rodents (38) as well as in humans (68). High-fructose diets lead to increased levels of uric acid, 65 via xanthine oxidase (XO) activation in the liver (10), and high uric acid levels are in turnassociated with increased vascular stiffness and CVD in women (16, 21, 47) . Importantly, uric 67 acid levels in the high-normal range have been associated with increased vascular stiffness in 68 women (21) and beneficial CVD effects of XO inhibition have been documented even in the 69 absence of frank hyperuricemia (39). In addition to uric acid production, XO activation in 70 cardiovascular tissue results in enhanced production of reactive oxygen species (ROS) and 71 increased expression of pro-inflammatory molecules in rodents and humans (28, 30, 48) , which 72 contribute to cardiovascular tissue damage. The association between hyperuricemia, obesity, and 73 CVD is well recognized in the literature, and frequently coexists with other features of the 74 metabolic syndrome, such as impaired glucose homeostasis (51). Conversely, pharmacologic XO 75 inhibition results in improvements in systemic inflammatory markers in pre-clinical models of 76 the metabolic syndrome (3, 46) as well as in humans (70). 77
However, the impact of XO inhibition on vascular stiffness and function remains to be 78 fully elucidated. A recent meta-analysis evaluating the effects of the XO inhibitor allopurinol on 79 vascular stiffness in humans was inconclusive (18), thus underscoring the need for additional 80 research in this area. In the present investigation, we test the hypothesis that XO inhibition 81 results in reduced WD-induced vascular stiffness and impaired aortic vasodilatory responses, in 82 part, via decreased vascular oxidative stress. Therefore, we utilized C57BL/6J female mice fed a 83 WD for 16 weeks in the presence or absence of allopurinol, a widely used XO inhibitor, which 84 reduces uric acid production and oxidative stress. We assessed in vivo and ex vivo vascular 85 stiffness, as well as aortic vasomotor responses along with markers of fibrosis and oxidative 86 stress both systemically and in aortic tissue. 87
Methods 88
Animal Models 89 topographical images of EC or VSMC, the AFM was operated in contact mode. The area of the 134 tissue surface that was scanned in these experiments was 40 x 40 μm and the digital density of 135 the scanned area was 512 × 512 pixels. Stylus type AFM probes (Model: MLCT-C, k = 15 136 pN/nm, Bruker, Santa Barbara, CA) were used to perform surface scanning at 0.4 Hz frequency 137 with approximately 300-500 pN tracking force (17). 138
Ex vivo Vasomotor Responses of Aortic Rings 139
Vasomotor responses were evaluated in the aorta via wire myography as previously 140 described (17, 42). Briefly, a 2 mm segment of thoracic aorta was collected immediately after 141 euthanasia and placed in the bathing physiological salt solution (PSS) containing (in mM): 145 142 NaCl, 4.7 KCl, 1.2 NaH 2 PO 4 , 1.17 MgSO 4 , 2 CaCl 2 , 5 glucose, 2 pyruvate, 0.02 EDTA, 3 143 MOPS, and 1% bovine serum albumin, pH 7.4. Samples were maintained at 37°C and were 144 continuously aerated with 95% O2 -5% CO2. Before experimentation, the aortic contractile state 145 was ascertained by KCl (80mM L−1). Aortas were pre-constricted with U46619 (100nM). -free PSS to determine minimal force 152 during passive conditions. 153
Vascular Fibrosis 154
A 2 mm segment of thoracic aorta was fixed in 3% paraformaldehyde, dehydrated in 155 ethanol, paraffin embedded, and transversely sectioned in 5µm slices. Four sections each for 4-5mice per group were examined. Slides were stained with picrosirius red stain and Verhoeff-Von 157
Gieson (VVG) stain to measure collagen accumulation. The areas and intensities of red color 158 which were stained with picrosirius red and the intensities of pink color on the VVG stained 159 sections indicative of collagen deposition were quantified as gray scale intensities using 160 MetaVue software as previously described (29) . 161 162
Measurement of vivo Aortic stiffness in vivo 163
We measured aortic stiffness in vivo by Pulse Wave Velocity (PWV). Doppler ultrasound (Indus 164
Mouse Doppler System, Webster, TX) was used as previously described in our laboratory (17) . 165
Prior to sacrifice, isoflurane-anesthetized mice (1.75% in 100% oxygen stream) were placed 166 supine on a heating board and legs secured to ECG electrodes. PWV was determined according 167 to the transit time method, calculated as the difference in arrival times of a Doppler pulse wave at 168 two locations along the aorta (aortic arch and descending aorta) which were set at a known 169 distance apart (35 mm). Each of the pulse wave arrival times was measured as the time from the 170 peak of the ECG R-wave to the leading foot of the pulse wave at which time velocity begins to 171 rise at the start of systole. The distance between the two locations along the aorta was divided by 172 transit time and data are expressed in mm/ms. Velocity waveforms were acquired at the aortic 173 arch followed immediately by measurement at the descending aorta proximal to the iliac 174 bifurcation (17). 175
176

Oxidative Stress 177
Aortic oxidative stress was assessed by immunostaining for 3-nitrotyrosine (3-NT) as 178 previously described (77). 3-NT is a product of tyrosine nitration mediated by ROS such asperoxynitrite, which promotes NO destruction as well as vascular inflammation (17, 29) . Briefly, 180 5 µm paraffin embedded Aorta sections from different treatments were dewaxed, rehydrated, 181 antigen retrieved and incubated overnight with 1:150 primary rabbit polyclonal anti-3-NT 182 antibody (Millipore). Sections were washed and incubated 30 min with secondary antibodies, 183 biotinylated anti rabbit, and streptavidin-HRP. After several rinses with distilled water, 184 diaminobenzidine (DAB) was applied for 7 minutes, and sections were again rinsed and stained 185 with hematoxylin for 90 seconds, dehydrated, and mounted with permount. 
Transmission electron microscopy (TEM) 209
Aorta samples were fixed in 2% paraformaldehyde, 2% glutaraldehyde in 100 mM sodium 210 cacodylate buffer pH=7.35. Fixed tissues were rinsed with 100 mM sodium cacodylate buffer, 211 containing 10 mM 2 mercaptoethanol and 130 mM sucrose (2-ME buffer). Secondary fixation 212 was performed using 1% osmium tetroxide in 2-ME buffer. Specimens were next incubated at 213 4°C for 1 hour, then rinsed with 2-ME buffer. Block staining was performed using 1% aqueous 214 uranyl acetate and incubated at 4°C overnight, then rinsed with distilled water. Sections were cut 215 to a thickness of 85 nm using an ultramicrotome and stained using Sato's triple lead solution 216 stain and 5% aqueous uranyl acetate. Multiple images were acquired for study at various 217 magnifications with a JEOL JEM 1400 transmission electron microscope at 80 kV. Specifically, 218 twelve endothelial images per group were acquired X800 and/or X1000 magnification for 219 measurement of EC length with existing scale bar on image. To measure EC length, 3 EC were 220 measured randomly from each sample at their base where they joined the internal elastic lamina 221 utilizing the scale bar of that image, for a total of 12 measurements for each sample. 222
223
Results
224
In agreement with previous data from our laboratory (41), 16 weeks of WD-feeding 226 resulted in a significant increase in body weight as well as fat percentage in all cohorts. 227
Administration of allopurinol did not affect these parameters (Fig 1A-B) . In parallel, fasting 228 blood glucose was elevated in the WD-fed cohorts relative to animals fed a control diet 229 (281.0±10.30 vs 217.75±27.30 mg/dL, p<0.05). Administration of allopurinol did not induce 230 significant changes in body composition or glucose metabolism in either the CD-fed or the WD-231 fed mice (Fig 1C) . These data support the notion that the effects of XO inhibition are 232 independent of changes on body weight, body composition or glucose metabolism. In male 233 C57BL/6J mice, we have previously demonstrated and published that 16-weeks of WD resulted 234 in a significant increase in uric acid levels (30). In the present investigation, WD resulted in a 235 non-statistical significant elevation of uric acid in the WD-fed female mice relative to animals 236 fed a CD (0.55±0.09 vs 0.40±0.05 mg/dL). Treatment with allopurinol did not affect uric acid 237 levels in CD-fed animals, but it substantially lowered uric acid levels in WD-fed female mice 238 compared to untreated WD-fed animals (0.21±0.04 vs 0.55±0.09 mg/dL, p<0.05) (Fig 1D) . In 239 addition, XO activity was increased by approximately 1.9 fold in WD female mice relative to 240 animals fed a CD (6.86±2.97 vs 3.61±0.37 U/L, p=0.35), and was significantly decreased by 241 allopurinol (1.51±0.27U/L, p<0.05). XO activity also trended down in CD-fed mice treated with 242 allopurinol as well (2.07±0.08 U/L, p=0.17). 243
244
XO inhibition protects against WD-induced aortic stiffness and impaired vasodilatory 245 responses
We have demonstrated and published previously that 16 weeks of WD feeding results in 247 increased cardiovascular stiffness in female mice (17, 41). In the current investigation, we 248 assessed vascular stiffness via AFM of thoracic aortic explants. We found that WD feeding 249 resulted in a significant increase in aortic stiffness as compared to CD (16.9± 0.50 vs 5.21± 0.54 250 kPa) (Fig 2A) . XO inhibition with allopurinol significantly reduced aortic stiffness to levels 251 comparable to animals fed a CD (16.9±0.50 vs 3.44± 0.50 kPa, p<0.05) (Fig 2A) . In addition, we 252 measured in vivo aortic stiffness by ultrasound-based PWV. We have previously demonstrated 253 significant increases in PWV in female mice fed a WD for 16 weeks relative to mice fed a CD 254 (17, 29, 42 endothelial-dependent and independent vasodilatory responses (17). Therefore, we evaluated 261 vasomotor responses only in the WD-fed cohorts. In isolated aortic rings, the cohort treated with 262 XO inhibitor had greater vasodilatory response to ACh when compared with the WD-fed animals 263 (E max =16.38±1.94% vs E max =27.46±2.80%, p<0.05) (Fig 2B) . Similarly, the endothelial-264 independent vasodilatory response to SNP was significantly greater in the WD-ALLO when 265 compared with WD (E max =28.50±4.55% vs 44.29%, p<0.05) (Fig 2C) . These responses were 266 restored to a degree comparable to female mice fed a CD (E max =35.1±2.20% and 38.9±2.70% for 267
ACh and SNP respectively), as previously published by our laboratory (17) . (Fig 3A) . Further, XO inhibition reduced MDA to levels similar to 277 those found in allopurinol treated control mice (2.05±0.26 μM, p>0.05). 278
Previously, we have determined that in females WD-induced aortic stiffness is related to 279 increased oxidative stress and vascular remodeling(17). Similarly, in the present investigation we 280 found increased 3-NT staining in the WD-fed cohort group when compared with CD (Fig 3B) . In 281 addition, XO inhibition significantly ameliorated oxidative stress (WD vs. WD-ALLO, Fig 3B.  282 These data, in addition to our results showing WD-induced increments in XO activity in aortic 283 tissue which is ameliorated by allopurinol, collectively suggest that XO inhibition is protective 284 against WD-induced vascular oxidative stress in female mice. 285
We also studied the impact of WD-induced enhancement of XO activity on fibrosis in 286 aortic tissue by immunohistochemistry. Relative to mice fed a CD, WD feeding for 16 weeks 287 resulted in increased collagen deposition, as measured by picrosirius red immunostaining (Fig 4) . 288
Allopurinol administration resulted in significant reductions in this marker of fibrosis in WD-fed 289 animals relative to untreated animals also fed a WD (WD-ALLO vs. WD). These data suggest a 290 beneficial influence of XO inhibition on vascular fibrosis in conditions of WD feeding (Fig 4) . 291
Finally, we analyzed ultrastructural changes via TEM in aortic samples. Our findings 292 demonstrate increased deposition of highly organized fibrillary collagen in WD-fed mice, which 293 correlates with our immunohistochemistry findings reported above (Fig 5) . Furthermore, we also 294 demonstrated an abnormal phenotype characterized by shortening and lifting of ECs, which is 295 suggestive of increased EC contractility (Fig 6) . Similar to our AFM and vasomotor responses, 296 these abnormalities were corrected by allopurinol. 297
298
Discussion 299
The central aim of the current investigation was to evaluate the impact of XO inhibition 300 on vascular stiffness in a female rodent model of chronic over-nutrition with a diet high in fat 301 and fructose (WD). Overall, our data demonstrate that XO inhibition improves WD-induced 302 vascular stiffness, as well as aortic vasodilatory responses. In addition, we show that these 303 actions of XO inhibition occur in concert with decreased oxidative stress and aortic fibrosis in 304 females. 305
Fructose is ubiquitously consumed in industrialized countries, mostly derived from 306 sucrose present in table sugar and high-fructose corn syrup, and typically leads to increased 307 levels of uric acid (71). As opposed to glucose, which is readily utilized by most cells to produce 308 energy, fructose must be further metabolized prior to joining the glycolytic pathway. In the liver, 309 fructokinase phosphorylates fructose to fructose-1-phosphate in an unregulated manner, leading 310 to depletion of adenosine triphosphate (ATP), which in turn results in stimulation of key 311 enzymes involved in purine nucleotide synthesis. Ultimately, this pathway leads to increased 312 activity of XO and subsequent production of uric acid (32, 33, 43) .
Although there is controversy in regards to the relative contribution of dietary fructose in 314 the development of CVD (62), high-fructose diets are currently under scrutiny due to their 315 potential impact on obesity, DM2 and CVD (6, 9, 40, 50, 63, 67) . It is accepted that increased 316 levels of uric acid as occurs with WD consumption are linked to increased risk for CVD (61), as 317 well as chronic kidney disease in humans (49). Nonetheless, other mechanisms have been 318 postulated to contribute to the development of vascular dysfunction and CVD, including 319 fructose-induced cardiovascular oxidative stress (30, 62). 320
We performed our studies in cycling female mice because of the translational relevance 321 related to observations in premenopausal women. To this point, the impact of dietary fructose on 322 vascular stiffness appears to have more severe implications in females than males. Indeed, in a 323 cohort of over 88,000 women, the consumption of high-fructose diet in the form of >2 sugar-324 sweetened beverages resulted in a 35% increased risk of coronary artery disease relative to men 325 (24). In a Japanese cohort of over 38,000 subjects, sugar-sweetened beverages were associated 326 with ischemic stroke in only women (20) . Similarly, it has been shown that high plasma levels of 327 uric acid are linked to increased vascular stiffness in apparently healthy women but not in men 328 (21). Furthermore, women exhibit increased vascular stiffness with aging, and insulin resistance 329 worsens this abnormality to a greater degree compared to men (56). Therefore, the augmented 330 incidence and greater severity of CV disease in obese and diabetic women can be partially 331 related to the presence of increased vascular stiffness (14, 64). Indeed, women with DM2 are at 332 an especially higher risk of developing coronary artery disease (36) and stroke compared to men 333 (57). 334
Our data support the notion that a key mediator of WD-induced vascular stiffness is 335 increased oxidative stress. The key role played by excess production of ROS in the pathogenesis 336 of CVD is well established and described (13, 45) . In addition, data from our laboratory have 337 demonstrated that ROS contributes to vascular remodeling, as well as stiffness in rodent models 338 of chronic over-nutrition (17, 29, 42) . In this study, we evaluated systemically oxidative stress by 339 measuring plasma levels of MDA, as well as at the tissue level via measurements of XO and 3-340 NT in aortic tissue. Our results demonstrate significantly increased plasma levels of MDA and 3-341 NT in vascular smooth muscle and endothelial cells, which were substantially reduced by 342 administration of allopurinol, to levels comparable to mice fed a CD and treated with allopurinol. 343
Moreover, similar results were demonstrated in our measurements of XO oxidase activity, which 344 is independently a major source of ROS and is known to participate in the pathogenesis of 345 vascular dysfunction leading to CVD (23). Therefore, our data do support a critical role for 346 oxidative stress as a mediator of WD-induced vascular stiffness in female mice. High-fructose diets can indeed trigger activation of alternative sources of ROS such as 359 NADPH oxidase (1, 5, 11). However, in our experiments treatment with allopurinol decreased 360 markers of oxidative stress and fibrosis, thus supporting the role of vascular XO activation as a 361 critical contributor to elevated ROS production in the setting of WD feeding. Indeed, we have 362 previously reported that WD feeding increases cardiovascular XO activity in males, and that 363 allopurinol treatment for 16 weeks mitigates this WD-mediated increase (30). 364
Interestingly, administration of allopurinol resulted in improvements in endothelial 365 stiffness in the absence of significant changes aortic stiffness in vivo (measured by PWV). These 366 findings suggest that improvement in endothelial cell stiffness is an earlier event that precedes 367 further changes in arterial stiffness in whole aorta. In agreement, data from our laboratory 368 obtained in female mice also fed a WD for 16 weeks have also reported changes in endothelial 369 stiffness in response to other interventions such as exercise, which do not result in in vivo 370 changes in PWV (54). 371
We also found improved vasomotor responses associated with XO inhibition ex vivo. 372
Utilizing wire myography, we detected increased both endothelium-dependent and independent 373 responses in aorta in our allopurinol-treated mice in conditions of WD feeding. Interestingly we 374 have previously reported aortic maximal relaxation reaching roughly 35-40% for ACh and 375 approximately 70% for SNP in female mice fed a CD (17, 29, 42) . Available literature has 376 reported comparable results to our published data (58, 59), whereas others studies report higher 377 vasomotor responses compared to our results in control animals under similar conditions (55, 378 76 We utilized allopurinol for XO inhibition since it is known to be safe and effective in the 389 clinical setting for the treatment of hyperuricemia. Furthermore, available literature has reported 390 potential additional benefits of this medication (18), such as improvements in endothelial 391 function (25), oxidative stress (26) and modulation of inflammation (2), which are contributors 392 to vascular stiffness. Nonetheless, the efficacy of allopurinol to improve vascular stiffness has 393 not been established (18) . 394
Remarkably, consumption of a WD induced only a non-significant increase in plasma 395 uric acid levels in our female mice. This modest response has been previously reported in several 396 studies dealing with high fructose diets used in humans (27) as well as in rodents (65), and 397 several reasons have been argued for this particular finding. Unlike humans in which uricase (the 398 enzyme that catalyzes conversion of uric acid into allantoin and allows its excretion) is absent, 399 this enzyme is present in rodents. Therefore, the impact of high-fructose diets on uric acid levels 400 in mice differs significantly, and elevations in serum levels of uric acid in response to high 401 fructose diets (66) are expected to be less significant compared to humans. Furthermore, similar 402 to glucose, fructose can be reabsorbed from the filtrate in the renal proximal tubule via 403 transporters such as GLUT 5 and GLUT 9, and hyperglycemia -present in our WD-fed mice-isassociated with impaired function of proximal tubules leading to decreased urate reabsorption (7, 405 8) . In addition, also in the setting of hyperglycemia, high concentrations of fructose reaching the 406 renal proximal tubules competitively inhibit urate reabsorption via GLUT 9, which can transport 407 both glucose and fructose (35). Collectively these phenomena result in reduced reabsorption of 408 urate and therefore to decreased plasma uric acid levels, as found in our experiments. 409
Furthermore, there is a dimorphic response regarding uric acid handling in mice and it has been 410 shown that elevations in uric acid are more substantial in males relative to females. Certainly, we 411 have previously published data demonstrating significant increases in plasma uric acid levels in 412 male mice fed a WD for 16 weeks (30), which in addition confirms the adequacy of the feeding 413 paradigm chosen for our study. Also, it has been shown that males have greater metabolism of 414 fructose in the proximal tubule, while females exhibit more substantial distal tubule 415 abnormalities regarding electrolyte balance (65). 416
In humans, available clinical studies support the therapeutic role of XO inhibition even in 417 the absence of frank hyperuricemia. In heart failure subjects, a high dose of allopurinol improved 418 forearm endothelial function as assessed by venous occlusion plethysmography (25) . 419
Remarkably, these findings were not dependent of reduction of uric acids levels and might have 420 been related to decreased oxidative stress (25). Another recent analysis of an elderly 421 hypertensive population dataset in the United Kingdom showed that in hypertensive individuals, 422 treatment with allopurinol was associated with 50% decreased risk of stroke and 30% risk of 423 cardiac events (39). Importantly, a multicenter, prospective, randomized, endpoint clinical study, the PRIZE study, is currently underway and will assess the effect of a 425 newer XO inhibitor -febuxostat -on carotid intima thickness in a population of asymptomatic 426 hyperuricemia subjects (53). This trial, designed to include 500 participants with uric acid >7.0mg/dL and carotid intima-media thickness ≥1.1 mm, will likely add valuable information 428 regarding the role of XO inhibition in the treatment of CVD. 429
Our findings of a reduction in WD-mediated vascular stiffness with allopurinol 430 contributes to a better understanding of the impact of XO activation on vascular stiffness in 431 females. However, additional studies comparing males to females are warranted and will 432 contribute to determining a possible differential CVD benefit from XO inhibition in females 433 compared to males. In addition, additional studies in cardiac tissue in females are needed to 434 better understand the sexual dimorphic impact of a WD, elevated uric acid, and XO activity on 435 cardiovascular stiffness and cardiac impaired relaxation. In this regard, data from our laboratory 436 in male mice fed a WD have already shown benefits of allopurinol on markers of cardiac 437 stiffness and diastolic dysfunction (30) . 438 Our results do not show a significant impact of XO inhibition on body weight, fat 439 percentage or fasting glycemia in mice exposed to WD. These data are suggestive that the 440 actions of allopurinol were not mediated by an indirect effect of XO inhibition on these 441 metabolic parameters. Instead, the beneficial actions of XO inhibition are likely resulting from 442 direct vascular effects such as decreased oxidative stress. We did not specifically measure 443 markers of insulin resistance, however the finding that the above-mentioned parameters 444 remained unchanged also supports the possibility of mechanisms not affecting insulin sensitivity 445 or glucose homeostasis. 446
In summary, this investigation demonstrates that XO inhibition and subsequent 447 reductions in systemic and vascular tissue oxidative stress play a protective role against WD-448 induced vascular stiffness in female mice. Because population studies suggest that hyperuricemia 449 has a more severe impact on vascular stiffness in females compared to males, our findings 450 stimulate the possibility that females consuming a WD may be specially benefited from 451 pharmacologic XO inhibition. Additional studies are required to determine the extent to which 452 reduced vascular stiffness with XO inhibition is mediated by a reduction in uric acid, and 453 whether this pharmacological treatment results in a significant reduction in the excessive CVD 454 morbidity and mortality found in insulin resistant women relative to men. 455 
